Tech Company Financing Transactions
Kaleo Software Funding Round
PDL BioPharma joined a $150 million venture round for Kaleo Software. This venture round was announced on 4/7/2014.
Transaction Overview
Company Name
Announced On
4/7/2014
Transaction Type
Debt
Amount
$150,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will enable kaleo to support the commercialization of EVZIO (approved by the FDA on April 3, 2014), to invest in the development of pipeline products and repay existing debt. EVZIO is intended for the emergency treatment of known or suspected opioid overdose, as manifested by life-threatening respiratory depression.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2041 Rosecrans Blvd. 245
El Segundo, CA 90245
USA
El Segundo, CA 90245
USA
Phone
Website
Email Address
Overview
Kaleo is an interactive knowledge network that puts the answers to essential business questions at a user's fingertips. Kaleo captures and tags information to create an organically growing knowledge base. Users can find information based on input from co-workers and topic experts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phil Hui-Bon-Hoa
Chief Technical Officer
John Lynch
VP - Customer Service
Mike Rossi
VP - Product Management
Matt Yang
Browse more venture capital transactions:
Prev: 4/7/2014: Cardiox venture capital transaction
Next: 4/7/2014: Little Pim venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs